Sodium nitroprusside treatment of ergotamine-induced peripheral ischemia

JAMA. 1974 Jan 21;227(3):308-9.
No abstract available

MeSH terms

  • Arm / blood supply*
  • Caffeine / adverse effects
  • Caffeine / therapeutic use
  • Ergotamine / adverse effects
  • Ergotamine / therapeutic use
  • Female
  • Ferricyanides / administration & dosage
  • Ferricyanides / therapeutic use*
  • Humans
  • Infusions, Parenteral
  • Ischemia / chemically induced
  • Ischemia / drug therapy*
  • Leg / blood supply*
  • Methods
  • Middle Aged
  • Nitric Oxide / administration & dosage
  • Nitric Oxide / therapeutic use
  • Suppositories / adverse effects
  • Suppositories / therapeutic use
  • Tartrates / adverse effects
  • Tartrates / therapeutic use
  • Vascular Headaches / drug therapy
  • Vasodilator Agents / administration & dosage
  • Vasodilator Agents / therapeutic use*

Substances

  • Ferricyanides
  • Suppositories
  • Tartrates
  • Vasodilator Agents
  • Nitric Oxide
  • Caffeine
  • Ergotamine